OGN News

Organon Completes Divestiture of JADA ® System to Laborie

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON ® (etonogestrel implant) 68 mg Radiopaque

Organon conclut un accord de commercialisation pour Nilemdo ® de Daiichi Sankyo en France, au Danemark, en Islande, en Suède, en Finlande et en Norvège

Organon sluit een akkoord voor de commercialisering van Daiichi Sankyo’s Nilemdo ® in Frankrijk, Denemarken, IJsland, Zweden, Finland en Noorwegen

Organon sottoscrive un accordo di commercializzazione relativo a Nilemdo ® di Daiichi Sankyo in Francia, Danimarca, Islanda, Svezia, Finlandia e Norvegia

Organon firma un acuerdo de comercialización para Nilemdo ® de Daiichi Sankyo en Francia, Dinamarca, Islandia, Suecia, Finlandia y Noruega

Organon schließt Vermarktungsvereinbarung für Nilemdo ® von Daiichi Sankyo in Frankreich, Dänemark, Island, Schweden, Finnland und Norwegen

Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo ® in France, Denmark, Iceland, Sweden, Finland and Norway

Orogen Royalties Notes Initial Resource Estimate on Kodiak Copper's MPD Copper-Gold Project

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference